Histomorphologic and molecular features of pouch and peripouch adenocarcinoma: A comparison with ulcerative colitis-associated adenocarcinoma

American Journal of Surgical Pathology

Volumn 36, Issue 9, 2012, Pages 1385-1394

  Jiang, Wei ^a   Shadrach, Bonnie ^a   Carver, Paula ^a   Goldblum, John R ^a   Shen, Bo ^a   Liu, Xiuli ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

catenin; CDX2; chromosomal instability; CK20; CK7; ileal pouch adenocarcinoma; microsatellite instability; p53; ulcerative colitisassociated adenocarcinoma

Indexed keywords

CDX2 PROTEIN, HUMAN; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; KERATIN; MSH3 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; COLON POUCH; COLON RESECTION; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROCTOCOLECTOMY; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; ULCERATIVE COLITIS;

ADENOCARCINOMA; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POUCHES; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; KERATINS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROCTOCOLECTOMY, RESTORATIVE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865463630     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825fa4b4     Document Type: Article

References (36)

1. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120-127.
2. Kariv R, Remzi FH, Lian L, et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterol. 2010;139:806-812.
3. Branco BC, Sachar DB, Heimann TM, et al. Adenocarcinoma following ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2009;15:295-299.
4. Obusez EC, Liu Y, Bennett AE, et al. Adenocarcinoma in the ileal pouch: early detection and potential role of fecal DNA methylated markers in surveillance. Int J Colorectal Dis. 2011;26:951-953.
5. Potack J, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease. Gut Liver. 2008;2:61-73.
6. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol. 2008;14:378-389. (Pubitemid 351320846)
7. Jass JR. Molecular heterogeneity of colorectal cancer: Implications for cancer control. Surg Oncol. 2007;(suppl 1):S7-S9.
8. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319: 525-532.
9. Brentnall TA, Rubin CE, Crispin DA, et al. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology. 1995;109: 151-155.
10. Fleisher AS, Esteller M, Harpaz N, et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res. 2000;60:4864-4868.
11. Laurent C, Svrcek M, Flejou J-F, et al. Immunohistochemical expression of CDX2, beta-catenin, and TP53 in inflamamtory bowel disease-associated colorectal cancer. Inflam Bowel Dis. 2011;17: 232-240.
12. Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126-133.
13. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986;10:437-459. (Pubitemid 16039125)
14. Gerrits MM, Chen M, Theeuwes M, et al. Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study. Cell Oncol. 2011;34:107-117.
15. Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis. 2009;15:284-294.
16. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228-1233. (Pubitemid 20366527)
17. Al-Sukhni W, McLeod RS, MacRae H, et al. Oncologic outcome in patients with ulcerative colitis associated with dysplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis. Dis Colon Rectum. 2010;53:1495-1500.
18. Naccarati A, Polakova V, Pardini B, et al. Mutations and polymorphisms in TP53 gene-an overview on the role in colorectal cancer. Mutagenesis. 2012;27:211-218.
19. Lugli A, Zlobec I, Minoo P, et al. Prognostic significance of the wnt signalling pathway molecules APC, b-catenin and E-cadherin in colorectal cancer-a tissue microarray-based analysis. Histopathology. 2007;50:453-464. (Pubitemid 46328181)
20. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science. 1993;262:1734-1737. (Pubitemid 24030097)
21. Wong SCC, Lo ESF, Lee KC, et al. Prognostic and diagnostic significance of b-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res. 2004;10:1401-1408. (Pubitemid 38365235)
22. Sanchez JA, Dejulius KL, Bronner M, et al. Relative role of methylator and tumor suppressor pathways in ulcerative colitisassociated colon cancer. Inflamm Bowel Dis. 2011;17:1966-1970.
23. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-1860.
24. Fujiwara I, Yashiro M, Kubo N, et al. Ulcerative colitis-associated colorectal cancer is freqquently associated with microsatellite intability pathway. Dis Colon Rectum. 2008;51:1387-1394.
25. Lyda MH, Noffsinger A, Belli J, et al. Microsatellite instability and K-ras mutations in patients with ulcerative colitis. Hum Pathol. 2000;31:665-671. (Pubitemid 30445468)
26. Noffsinger AE, Belli JM, Fogt F, et al. germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis. Hum Pathol. 1999;30:8-12. (Pubitemid 29037387)
27. Noffsinger A, Kretschmer S, Belli J, et al. Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease. Dig Dis Sci. 2000;45:378-384. (Pubitemid 30133902)
28. van Dieren JMWJ, Vissers KJ, van Marion R, et al. Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis. Diagn Mol Pathol. 2006;15:216-222. (Pubitemid 44813660)
29. Yagishita H, Yoshida T, Ishiguro K, et al. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis. Scand J Gastroenterol. 2008; 43:559-566. (Pubitemid 351536049)
30. Nishigami T, Kataoka T, Ikeuchi H, et al. Adenocarcinomas associated with perianal fistulae in Crohn's disease have a rectal, not anal, immunophenotype. Pathology. 2011;43:36-39.
31. Meriden Z, Montgomery EA. Anal duct carcinoma: a report of 5 cases. Hum Pathol. 2012;43:216-220.
32. Bayrak R, Yenidunava S, Haltas H. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. Pathol Res Pract. 2011;207:156-160.
33. Chen ZM, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol. 2004;28:1352-1359. (Pubitemid 39336375)
34. Harbaum L, Pollheimer MJ, Kornprat P, et al. Keratin 7 expression in colorectal cancer-freak of nature or significant finding? Histopathology. 2011;59:225-234.
35. Levi GS, Harpaz N. Intestinal low-grade tubuloglandular adenocarcinoma in inflammaory bowel disease. Am J Surg Pathol. 2006;30:1022-1029. (Pubitemid 44264953)
36. Tatsumi N, Kushima R, Vieth M, et al. Cytokeratin 7/20 and mucin core protein expression in uclerative colitis-asscoiated colorectal tumors. Virchow Arch. 2006;448:756-762. (Pubitemid 43824432)